A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.

H. Venkataraman, SB de Beer, LA Bergen, N van Essen, D.P. Geerke, N.P.E. Vermeulen, J.N.M. Commandeur

Research output: Contribution to Journal › Article › Academic › peer-review

Access to Document

@article{f0b4386d97af4044a7e3995a7c78c5bf,

title = "A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.",

author = "H. Venkataraman and {de Beer}, SB and LA Bergen and {van Essen}, N and D.P. Geerke and N.P.E. Vermeulen and J.N.M. Commandeur",

year = "2012",

doi = "10.1002/cbic.201100750",

language = "English",

volume = "13",

pages = "520--523",

journal = "ChemBioChem",

issn = "1439-4227",

publisher = "Wiley-VCH Verlag",

number = "4",

}

TY - JOUR

T1 - A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.

AU - Venkataraman, H.

AU - de Beer, SB

AU - Bergen, LA

AU - van Essen, N

AU - Geerke, D.P.

AU - Vermeulen, N.P.E.

AU - Commandeur, J.N.M.

PY - 2012

Y1 - 2012

U2 - 10.1002/cbic.201100750

DO - 10.1002/cbic.201100750

M3 - Article

SN - 1439-4227

VL - 13

SP - 520

EP - 523

JO - ChemBioChem

JF - ChemBioChem

IS - 4

ER -